Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anaphylaxis associated with omalizumab administration: Risk factors and patient characteristics.

Literature DB >> 28797731

Anaphylaxis associated with omalizumab administration: Risk factors and patient characteristics.

Phillip L Lieberman¹, Ilisten Jones², Richa Rajwanshi³, Karin Rosén³, Dale T Umetsu⁴.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2017 PMID： 28797731 DOI： 10.1016/j.jaci.2017.07.013

Source DB: PubMed Journal: J Allergy Clin Immunol ISSN： 0091-6749 Impact factor: 10.793

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

1. The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors.

Authors: Bianca Balbino; Pauline Herviou; Ophélie Godon; Julien Stackowicz; Odile Richard-Le Goff; Bruno Iannascoli; Delphine Sterlin; Sébastien Brûlé; Gael A Millot; Faith M Harris; Vera A Voronina; Kari C Nadeau; Lynn E Macdonald; Andrew J Murphy; Pierre Bruhns; Laurent L Reber
Journal: J Clin Invest Date: 2020-03-02 Impact factor: 14.808

2. Development and Utility of an ELISA Method for Sensitive and Specific Detection of IgE Antidrug Antibodies.

Authors: Zhandong Don Zhong; Lynn L Jiang; Puneet Khandelwal; Adam W Clarke; Ray Bakhtiar; Linglong Zou
Journal: AAPS J Date: 2020-01-29 Impact factor: 4.009

Review 3. Past, present, and future of anti-IgE biologics.

Authors: Pascal Guntern; Alexander Eggel
Journal: Allergy Date: 2020-04-21 Impact factor: 13.146

4. Multicentre experience of home omalizumab treatment for chronic spontaneous urticaria.

Authors: Sarah Denman; Tariq El-Shanaway; Emily Carne; Lisa Devlin; Sinisa Savic
Journal: Eur J Hosp Pharm Date: 2019-07-15

Review 5. The use of biologic therapies for the management of pediatric asthma.

Authors: Stephanie Lovinsky-Desir
Journal: Pediatr Pulmonol Date: 2019-12-27

Review 6. Chronic Urticaria: Advances in Understanding of the Disease and Clinical Management.

Authors: Liting He; Wanyu Yi; Xin Huang; Hai Long; Qianjin Lu
Journal: Clin Rev Allergy Immunol Date: 2021-09-16 Impact factor: 8.667

Review 7. Emerging Causes of Drug-Induced Anaphylaxis: A Review of Anaphylaxis-Associated Reports in the FDA Adverse Event Reporting System (FAERS).

Authors: Roger J Yu; Matthew S Krantz; Elizabeth J Phillips; Cosby A Stone
Journal: J Allergy Clin Immunol Pract Date: 2020-09-28